{{Infobox drug
| drug_name = 
| IUPAC_name = (2''E'')-[(4''R'')-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene](1''H''-imidazol-1-yl)acetonitrile
| image = Luliconazole.svg
| image2 = Luliconazole ball-and-stick model.png
| alt = 
| caption =

<!--Clinical data -->
| tradename = Luzu, Lulicon, LULY
| Drugs.com = 
| MedlinePlus = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category= 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = Topical

<!--Pharmacokinetic data -->
| bioavailability = 
| protein_bound = >99%<ref name='PI'>{{cite web|title=LUZU (luliconazole) Cream, 1%. Full Prescribing Information.|url=http://www.valeant.com/Portals/25/Pdf/PI/Luzurx-PI.pdf|publisher=Valeant Pharmaceuticals North America LLC|accessdate=1 October 2015}}</ref>
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers -->
| ATCvet = 
| ATC_prefix = D01
| ATC_suffix = AC18
| ATC_supplemental =
| DrugBank = 
| CAS_number = 187164-19-8
| PubChem = 3003141
| ChemSpiderID = 2273807
| smiles = C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl
| StdInChI = 1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1
| StdInChIKey = YTAOBBFIOAEMLL-REQDGWNSSA-N

<!--Chemical data -->
| C=14 | H=9 | Cl=2 | N=3 | S=2
| molecular_weight  = 354.28 g/mol
}}

'''Luliconazole''' (trade names '''Luzu''', '''Lulicon''') is an [[imidazole antifungal]] drug.  As a 1% [[Topical medication|topical]] cream, It is indicated for the treatment of [[athlete's foot]], [[jock itch]], and [[ringworm]] caused by [[dermatophytes]] such as ''[[Trichophyton rubrum]]'', ''[[Microsporum gypseum]]''<ref>{{cite news|url=http://formularyjournal.modernmedicine.com/formulary-journal/news/fda-approves-luliconazole-tinea-pedis|title=FDA approves luliconazole for tinea pedis|date=November 19, 2013|accessdate=14 January 2014}}</ref> and ''[[Epidermophyton floccosum]].<ref name='PI' />

==References==
{{reflist}}

==External links==
* [http://www.topicapharma.com/luliconazole-molecule Luliconazole]

{{Antifungals}}

[[Category:Dithiolanes]]
[[Category:Nitriles]]
[[Category:Chloroarenes]]
[[Category:Antifungals]]
[[Category:Fungicides]]
[[Category:Lanosterol 14Î±-demethylase inhibitors]]


{{dermatologic-drug-stub}}